GHRP-2 (5 mg vial)

Protocol Overview

Concise summary of the regimen.

Dosing & Reconstitution

Frequency: Inject once daily subcutaneously. This once-daily schedule balances efficacy with receptor recovery time, avoiding the rapid attenuation seen with frequent dosing. Administering in the evening may capitalize on nocturnal GH rhythms. For 10 unit (0.10 mL) or smaller administrations, consider 30- or 50-unit insulin syringes for improved readability.

Reconstitution Steps

1. Draw 3.0 mL bacteriostatic water with a sterile syringe.
2. Inject slowly down the vial wall; avoid foaming.
3. Gently swirl or roll until completely dissolved (do not shake).
4. Label and refrigerate at 2 to 8 °C, protected from light. At 1.67 mg/mL, 1 unit = 0.01 mL » 16.7 mcg on a U-100 insulin syringe.

Storage Instructions

Proper storage preserves peptide quality.

• Lyophilized: store at -20 °C in dry, dark conditions; powder is stable at room temperature for short

periods but freezer storage maximizes shelf life.

• Reconstituted: refrigerate at 2 to 8 °C; use within 2 to 3 weeks for optimal integrity.
• For longer storage, consider aliquoting and freezing at -20 °C with carrier protein; avoid repeated

freeze-thaw cycles.

• Allow vials to reach room temperature before opening to reduce condensation uptake. Always protect

from light and heat.

Supplies Needed

Plan based on an 8 to 16 week daily protocol with gradual titration.

Peptide Vials (GHRP-2, 5 mg each):

• 8 weeks: ~2 vials. 12 weeks: ~4 vials. 16 weeks: ~5 vials.

Insulin Syringes (U-100):

• Per week: 7 syringes (1/day).
• 8 weeks: 56. 12 weeks: 84. 16 weeks: 112.

Bacteriostatic Water (10 mL bottles):

• 8 weeks (2 vials): 1 bottle. 12 weeks (4 vials): 2 bottles. 16 weeks (5 vials): 2 bottles.

Alcohol Swabs:

• Per week: 14 swabs.
• 8 weeks: 112 (2 x 100-count). 16 weeks: 224 (3 x 100-count).

Important Notes

Practical considerations for consistency and safety.

• Use new sterile insulin syringes for each injection; dispose in a sharps container.
• Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation and prevent lipodystrophy.
• Very frequent dosing (e.g., every 2 hours) can cause progressive attenuation due to acute tachyphylaxis;

once-daily administration avoids this issue.

• Multiple daily injections (2 to 3 times) have been explored but require strict adherence and may offer

limited added benefit.

• Document daily dose and site rotation to maintain consistency.

How This Works

GHRP-2 is a synthetic growth hormone secretagogue that binds to and activates ghrelin (GH secretagogue) receptors. This activation triggers potent, pulsatile release of growth hormone from the pituitary gland in a dose-dependent manner. Clinical studies in GH-deficient children demonstrated meaningful GH increases even at low doses (0.3 to 3.0 mcg/kg), with escalating doses over several months showing sustained efficacy. In healthy adults, doses of 100 mcg SC daily produce acute GH stimulation, while routine protocols typically maintain 100 to 300 mcg/day to balance efficacy with receptor sensitivity. The peptide has been well tolerated in clinical trials with no significant adverse effects or toxicity reported at these dosage ranges.

Benefits & Side Effects

Observations from clinical and preclinical literature.

• Stimulates robust pulsatile GH release that may support favorable body composition changes and

metabolic effects.

• In combination therapies (e.g., with GHRH analogs), can significantly increase IGF-1 levels when

administered with perfect compliance.

• Generally well tolerated with placebo-like safety profile; transient side effects may include mild hunger

sensation or flushing.

• Long-term therapy (8 to 24 months in GH-deficient subjects) has maintained positive effects on growth

velocity with careful monitoring.

• Occasional mild injection-site reactions (redness, irritation) may occur with subcutaneous administration.

Lifestyle Factors

Complementary strategies for best outcomes.

• Maintain adequate protein intake and balanced nutrition to support the anabolic effects of elevated GH.
• Combine with resistance training to maximize body composition benefits.
• Prioritize sleep quality, as GH pulses naturally occur during deep sleep; evening administration may

complement this rhythm.

• Manage stress effectively to support consistent adherence and recovery.
• Stay well hydrated to support metabolic processes.

Injection Technique

General subcutaneous guidance from clinical best-practice resources.

1. Clean the vial stopper and skin with alcohol; allow to dry.
2. Pinch a skinfold; insert the needle at 45 to 90 degrees into subcutaneous tissue.
3. Do not aspirate for subcutaneous injections; inject slowly and steadily.
4. Wait 5 to 10 seconds before withdrawing; dispose of syringe in sharps container.
5. Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy.

References

Source citations for further reading.

1. Effects of GHRP-2 on GH release and growth performance (Domestic Animal Endocrinology).
2. Effects of eight months treatment with graded doses of GHRP-2 in GH-deficient children (J Clin Endocrinol Metab).
3. Five-day treatment with daily subcutaneous GHRP-2: response attenuation and IGF-I effects in healthy young men (Eur J Endocrinol).
4. GH/IGF-1 response to acute and chronic GHRP-2, GHRH 1-44, and their combination in older adults (Endocrine).